J1050 HCPCS code: Injection, medroxyprogesterone acetate, 1 mg
J1050 is the HCPCS Level II code for injection, medroxyprogesterone acetate, 1 mg. In 2024 Medicare paid an average of $0.18 per service for J1050 across 796,072 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1000 per day on outpatient hospital claims. Medicare volume fell 35% from 2022 to 2024 (1,224,105 to 796,072 services). In 2024, about 2,704 clinicians billed Medicare for J1050 for 2,754 beneficiaries; Texas, Arkansas, Colorado accounted for 27% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2013-01-01 |
| Last action effective | 2013-01-01 |
Who bills J1050 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,704 |
| Medicare beneficiaries | 2,754 |
| States with claims | 40 |
| Share of services in top 3 states (Texas, Arkansas, Colorado) | 27% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1050, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,224,105 | 4,437 | $0.40 | $0.25 |
| 2023 | 829,745 | 2,912 | $0.24 | $0.17 |
| 2024 | 796,072 | 2,754 | $0.26 | $0.18 |
States with the most J1050 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 94,161 | $0.02 |
| Arkansas | 58,459 | $0.01 |
| Colorado | 58,079 | $0.01 |
| Pennsylvania | 54,500 | $0.01 |
| Ohio | 37,162 | $0.26 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1000 | Prescribing Information |
| practitioner claims | 1000 | Prescribing Information |
What changed for J1050
- 2013-01-01: J1050 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1050?
J1050 is the HCPCS Level II code for injection, medroxyprogesterone acetate, 1 mg. Short descriptor: "Medroxyprogesterone acetate".
How much does Medicare pay for J1050?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.26).
Does Medicare cover J1050?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1050 can be billed per day?
1000 on outpatient hospital claims; 1000 on practitioner claims (NCCI medically unlikely edits).
Related J10 codes
- J1000 — Injection, depo-estradiol cypionate, up to 5 mg
- J1010 — Injection, methylprednisolone acetate, 1 mg
- J1020 — Injection, methylprednisolone acetate, 20 mg
- J1030 — Injection, methylprednisolone acetate, 40 mg
- J1040 — Injection, methylprednisolone acetate, 80 mg
- J1060 — Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 — Injection, testosterone cypionate, up to 100 mg
- J1071 — Injection, testosterone cypionate, 1 mg
- J1072 — Injection, testosterone cypionate (azmiro), 1 mg
- J1073 — Testosterone pellet, implant, 75 mg
- J1080 — Injection, testosterone cypionate, 1 cc, 200 mg
- J1094 — Injection, dexamethasone acetate, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1050
- Watch J1050 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1050
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.